new_0222_0361|VINC|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment
new_0222_0361|VINC|Long Name|1|1|Vincerx Pharma Inc Total Current Assets (Quarterly) (USD)|Vincerx Pharma Inc Cash and Short Term Investments (Quarterly) (USD)|Vincerx Pharma Inc Inventories (Quarterly) (USD)|Vincerx Pharma Inc Net PP&E (Quarterly) (USD)|Vincerx Pharma Inc Goodwill and Intangibles (Quarterly) (USD)|Vincerx Pharma Inc Total Liabilities (Quarterly) (USD)|Vincerx Pharma Inc Total Current Liabilities (Quarterly) (USD)|Vincerx Pharma Inc Total Long Term Liabilities (Quarterly) (USD)|Vincerx Pharma Inc Total Deposits (Quarterly) (USD)|Vincerx Pharma Inc Book Value (Quarterly) (USD)|Vincerx Pharma Inc Retained Earnings (Quarterly) (USD)|Vincerx Pharma Inc Treasury Stock (Quarterly) (USD)|Vincerx Pharma Inc EV to Revenues|Vincerx Pharma Inc EV to Earnings|Vincerx Pharma Inc EV to Free Cash Flow|Vincerx Pharma Inc EV to Assets (Quarterly)|Vincerx Pharma Inc PS Ratio|Vincerx Pharma Inc PE Ratio|Vincerx Pharma Inc Price to Book Value|Vincerx Pharma Inc PEG Ratio|Vincerx Pharma Inc Debt to Equity Ratio|Vincerx Pharma Inc Dividend Yield|Vincerx Pharma Inc Shareholder Yield (TTM)|Vincerx Pharma Inc Percent of Shares Outstanding Short|Vincerx Pharma Inc Total Receivables (Quarterly) (USD)|Vincerx Pharma Inc Total Payables (Quarterly) (USD)|Vincerx Pharma Inc Total Capital Stock (Quarterly) (USD)|Vincerx Pharma Inc Return on Invested Capital|Vincerx Pharma Inc Quality Ratio Score|Vincerx Pharma Inc Momentum Score|Vincerx Pharma Inc Beta (1Y)|Vincerx Pharma Inc Sustainable Growth Rate (TTM)|Vincerx Pharma Inc Institutional Investor Ownership Percentage|Vincerx Pharma Inc Average Diluted Shares Outstanding (Quarterly)|Vincerx Pharma Inc Total Employees (Annual)|Vincerx Pharma Inc EPS Diluted (Quarterly) (USD)|Vincerx Pharma Inc SG&A Expense (Quarterly) (USD)|Vincerx Pharma Inc Shares Outstanding|Vincerx Pharma Inc Repurchase of Capital Stock (Quarterly) (USD)|Vincerx Pharma Inc Ordinary Shares Number (Quarterly)|Vincerx Pharma Inc Payout Ratio|Vincerx Pharma Inc Quick Ratio (Quarterly)|Vincerx Pharma Inc Normalized Diluted EPS (Quarterly) (USD)|Vincerx Pharma Inc Stock Buybacks (Quarterly) (USD)|Vincerx Pharma Inc Effective Tax Rate (TTM)|Vincerx Pharma Inc Return on Equity|Vincerx Pharma Inc Net Income (TTM) (USD)|Vincerx Pharma Inc Revenue (TTM) (USD)|Vincerx Pharma Inc Dividend Per Share (Quarterly) (USD)|Vincerx Pharma Inc Revenue (Quarterly) (USD)|Vincerx Pharma Inc Gross Profit (Quarterly) (USD)|Vincerx Pharma Inc Pre-Tax Income (Quarterly) (USD)|Vincerx Pharma Inc Net Income (Quarterly) (USD)|Vincerx Pharma Inc Net Interest Income (Quarterly) (USD)|Vincerx Pharma Inc Price (USD)|Vincerx Pharma Inc Total Return Price (USD)|Vincerx Pharma Inc Enterprise Value (USD)|Vincerx Pharma Inc 30-Day Average Daily Volume|Vincerx Pharma Inc 1 Year Price Returns (Daily)|Vincerx Pharma Inc Short Interest|Vincerx Pharma Inc PE Ratio (Forward)|Vincerx Pharma Inc PE Ratio (Forward 1y)|Vincerx Pharma Inc PS Ratio (Forward)|Vincerx Pharma Inc PS Ratio (Forward 1y)|Vincerx Pharma Inc Quarterly EPS Estimates (USD)|Vincerx Pharma Inc Quarterly Revenue Estimates (USD)|Vincerx Pharma Inc Quarterly EPS Surprise|Vincerx Pharma Inc Quarterly Revenue Surprise|Vincerx Pharma Inc Quarterly Actual EPS (USD)|Vincerx Pharma Inc Quarterly Actual Revenue (USD)|Vincerx Pharma Inc Revenue Estimates for Current Fiscal Year (USD)|Vincerx Pharma Inc Revenue Estimates for Next Fiscal Year (USD)|Vincerx Pharma Inc Price Target (USD)|Vincerx Pharma Inc Consensus Recommendation|Vincerx Pharma Inc Price Target Num Estimates|Vincerx Pharma Inc EPS Estimates for Current Fiscal Year (USD)|Vincerx Pharma Inc EPS Estimates for Next Fiscal Year (USD)|Vincerx Pharma Inc Research and Development Expense (Quarterly) (USD)|Vincerx Pharma Inc Reconciled Depreciation (Quarterly) (USD)|Vincerx Pharma Inc Non-Operating Interest Expense (Quarterly) (USD)|Vincerx Pharma Inc Land and Improvements (Quarterly) (USD)|Vincerx Pharma Inc Buildings and Improvements (Quarterly) (USD)|Vincerx Pharma Inc Other Properties (Quarterly) (USD)|Vincerx Pharma Inc Machine, Furniture & Equipment (Quarterly) (USD)
new_0222_0361|VINC|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric
new_0222_0361|VINC||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0361|VINC||5|5|91.25|91.25|0|91.5|0|91.25|91.25|91.25|0|91.25|91.25|0|0|0|1.44755244755|0|0|0|1.44755244755|0|0|1.44292237443|0|15.2307692308|0|91.25|91.25|0|0|30.7142857143|30.625|0|30.4615384615|91.3333333333|0|91.3333333333|91.3333333333|25.9166666667|0|91.25|0|0|91.3333333333|91.25|0|0|91|0|0|0|0|91.3333333333|91.3333333333|0|1.44292237443|1.44292237443|1.45172413793|1.44254278729|1.44324324324|15.2307692308|0|0|0|0|91.4285714286|91.4|91.5|0|91.5|0|37.9|53.2857142857|26.6428571429|19.380952381|26.6428571429|23.6875|24.8666666667|91.3333333333|91.3333333333|0|0|0|91.5|0
new_0222_0361|VINC||6|6|4|4|0|2|0|4|4|4|0|4|4|0|0|0|286|0|0|0|286|0|0|438|0|26|0|4|4|0|0|7|8|0|13|6|0|6|6|12|0|4|0|0|6|4|0|0|3|0|0|0|0|6|6|0|438|438|290|409|185|26|0|0|0|0|7|5|2|0|2|0|10|7|14|21|14|16|15|6|6|0|0|0|2|0
new_0222_0361|VINC||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0361|VINC|202003|202003|202003||||||||||||||||||||||||||||||||||5.076||-0.0008|0.004||||||-0.0008|||||||||-0.004|-0.004|||||||||||||||||||||||||0|0|||||
new_0222_0361|VINC|202005|202003|202003||||||||||||||||||||||0|||||||||||||||||||||||||||||||||10.69|10.69||||||||||||||||||||||||||||
new_0222_0361|VINC|202006|202006|202006||||||||||||||||||||||0||||||||||||5.009||-0.01|0.033||||||-0.01|||||||||-0.033|-0.033||9.96|9.96||||||||||||||||||||||0|0|||||
new_0222_0361|VINC|202007|202006|202006||||||||||||||||||||||0|||||||||||||||||||||||||||||||||10.135|10.135||4802.4||||||||||||||||||||||||||
new_0222_0361|VINC|202008|202006|202006||||||||||||||||||||||0|||||||||||||||||||||||||||||||||10.05|10.05||4630.5667||||||||||||||||||||||||||
new_0222_0361|VINC|202009|202009|202009|0.4755|0.0363||||0.8594|0.6575|0.2019||-0.3839|-0.3886|||||||||||0||||0.6575|0.001|||||||5.076||-0.06|0.305|||13.9844|||-0.06|0||||||||-0.307|-0.307||12.4|12.4||36360.8667||||||||||||||||||||0|0|||||
new_0222_0361|VINC|202010|202009|202009||||||||||||||||||||||0|||||||||||||||||||||||||||||||||15.48|15.48||75329.4667||||||||||||||||||||||||||
new_0222_0361|VINC|202011|202009|202009||||||||||||||||||||||0|||||||||||||||||||||||||||||||||16.5|16.5||13962.0667||||||||||||||||||||||||||
new_0222_0361|VINC|202012|202012|202012|63.11|61.792||||37.813|37.813|0||25.379|-16.665||||-101.1943||||11.5219|||0||0.2506||5.505|0.001||||||37.1218|5.954|28|-3.09|3.256|13.9844||13.9844|||-3.09||||-16.62|||||-16.276|-16.276||20.91|20.91|230.6218|19970.2667||35046|||||||||||0|||||-0.09||7.116||||||
new_0222_0361|VINC|202101|202012|202012|||||||||||||||-90.0264||||10.519|||0||2.4095|||||||||37.1443||||||||||||||||||||||19.09|19.09|205.1702|60346.3333||336954|||||||||||0|0|33|1|2|-1.82|-1.88|||||||
new_0222_0361|VINC|202102|202012|202012|||||||||||||||-91.315||||10.6347|||0||3.3517|||||||||38.4904||||||||||||||||||||||19.3|19.3|208.1069|99808.6333||468713||||||||||||||||||||||||
new_0222_0361|VINC|202103|202103|202103|54.408|53.355||3.372||32.447|29.171|3.276||25.553|-22.941||||-40.2862||||11.0997|||0||4.2322||0.461|0.001||||||84.7213|13.735||-0.46|4.791|14.6959||14.6959|||-0.7038||||-22.892|||||-6.276|-6.276||19.3|19.3|230.2759|132335.3667||621965|||||-0.3||-53.3333||-0.46||||33|1|2|-1.24|-1.82|4.834|-0.025||||3.372|
new_0222_0361|VINC|202104|202103|202103|||||||||||||||-31.8019||||9.2018|||0||3.6936|||||||||85.0961||||||||||||||||||||||16|16|181.7794|79590.9||542807|||||||||||||33|1|2|-1.655|-1.34|||||||
new_0222_0361|VINC|202105|202103|202103|||||||||||||||-33.2117||||9.5172|||0||2.8004|||||||-0.9636||71.4329|||||17.5211|||||||||||||||||13.88|13.88|189.8379|81212.1|48.4492|490662||||||||||||||1||-1.24||||||||
new_0222_0361|VINC|202106|202106|202106|86.505|85.623||4.445||19.542|15.684|3.858||71.595|-24.975||||-10.2207||||3.179|||0||4.3485||1.83|0.001|||4|-0.9853||85.1902|16.35||-0.12|6.695|17.5211||17.5211|||-1.0594||||-24.893|||||-2.034|-2.034||12.99|12.99|141.9761|176690.1|30.4217|761912|||||-0.3||60||-0.12|||||1||||10.698|-0.026||||4.445|
new_0222_0361|VINC|202107|202106|202106|||||||||||||||-10.5487||||3.2426|||0||4.1448||||||5|-1.0012||85.2446|||||17.5211|||||||||||||||||13.25|13.25|146.5316|179214.5333|30.7351|726214||||||||||||||||||||||||
new_0222_0361|VINC|202108|202106|202106|||||||||||||||-13.6137||||3.8373|||0||6.5977||||||5|-0.9507||85.2201||||||||||||||||||||||15.68|15.68|189.1078|121375.7667|56.0199|1155991|||||||||||0|0|29.6667|1|3|-2.66|-2.875|||||||
new_0222_0361|VINC|202109|202109|202109|123.248|122.796||4.419||28.799|25.162|3.637||100.626|-49.499||||-9.0273||||3.378|||0||5.8986||2.259|0.002|||7|-0.1905||80.8027|17.694||-1.39|5.72|21.0211||21.0211|||-1.0167|-47.499|||-49.11|||||-24.524|-24.524||16.17|16.17|217.1152|179149.5333|30.4032|1239959|||||-0.8525|0|-18.827||-1.013|0|0|0|29.75|1.25|4|-2.7025|-3.2667|12.211|0.048||||4.419|
new_0222_0361|VINC|202110|202109|202109|||||||||||||||-7.1044||||2.9184|||0||3.6469||||||5|0.1522||81.1109|||||21.0211|||||||||||||||||13.97|13.97|170.8688|73557.4333|-9.871|766608||||||||||||||||||||||||
new_0222_0361|VINC|202111|202109|202109|||||||||||||||-4.0628||||2.1914|||0||3.4715||||||3|0.332||81.1617||||||||||||||||||||||10.49|10.49|97.7153|61215.4667|-36.4242|729742|||||||||||0|0|28.6|1.2|5|-3.04|-3.2275|||||||
new_0222_0361|VINC|202112|202112|202112|||||||||||||||-3.8006||||2.1287|||0||3.9467||||||2|-0.1192||81.9681||||||||||||||||||||||10.19|10.19|91.409|93510.4667|-51.2673|831080|||||-1.0029|0|||||0|0|27.5|1.1667|6|-3.1743|-3.2183|||||||
new_0222_0361|VINC|202201|202112|202112|||||||||||||||-1.1786||||1.502|||0||5.4004||||||2|0.9496||79.082||||||||||||||||||||||7.19|7.19|28.3457|157869.8667|-62.3363|1137183|||||||||||0|0|27.1429|1.2857|7|-3.3157|-3.5775|||||||
new_0222_0361|VINC|202202|202112|202112|||||||||||||||-0.1297||||1.2513|||0|||||||||||||||||||||||||||||||||5.99|5.99|3.1204|166306.8|-66.9608|||||||||||||||1.2857||||||||||
new_0222_0361|VINC|202203|202203|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.905|0||||||||||||||||||
new_0222_0361|VINC|202206|202206|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.95|0||||||||||||||||||
new_0222_0361|VINC|202209|202209|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.995|0||||||||||||||||||
new_0222_0361|VINC|202212|202212|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.965|0||||||||||||||||||